Champlain Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RB Global
RBA
|
+$51.9M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
+$51.2M |
| 3 |
LNCE
Snyders-Lance, Inc.
LNCE
|
+$46M |
| 4 |
Hormel Foods
HRL
|
+$40.1M |
| 5 |
Verisk Analytics
VRSK
|
+$36.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APFH
AdvancePierre Foods Holdings
APFH
|
+$72.7M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$70.9M |
| 3 |
CST
CST Brands, Inc.
CST
|
+$32.9M |
| 4 |
RBC Bearings
RBC
|
+$29.7M |
| 5 |
Donaldson
DCI
|
+$29.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.09% |
| 2 | Technology | 17.08% |
| 3 | Industrials | 16.69% |
| 4 | Financials | 14.61% |
| 5 | Consumer Staples | 13.99% |
Similar funds
Champlain Investment Partners's Q2 2017 Portfolio in Review
As of Q2 2017, Champlain Investment Partners held 126 positions worth $8.18B, up 7.6% from $7.61B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Champlain Investment Partners deployed $287M of net new capital in Q2 2017, opening 11 new positions and adding to 85 existing holdings. Its largest new stake was CATALENT, INC.: 1,558,010 shares worth $54.7M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Dover, an estimated $21.2M trimmed.
- Champlain Investment Partners's largest Q2 2017 buy was CATALENT, INC.: 1,558,010 shares worth $54.7M.
- Champlain Investment Partners added most to RB Global in Q2 2017, an estimated $51.9M increase.
- Champlain Investment Partners's biggest Q2 2017 reduction was Dover, cutting an estimated $21.2M.
- Champlain Investment Partners fully exited AdvancePierre Foods Holdings in Q2 2017, selling an estimated $72.7M.
- Champlain Investment Partners's ten largest holdings make up 22% of its $8.18B portfolio in Q2 2017.
- Champlain Investment Partners opened 11 new positions and closed 9 in Q2 2017.
- Champlain Investment Partners's portfolio value rose 7.6% quarter-over-quarter to $8.18B.
Based on Champlain Investment Partners's 13F filing for Q2 2017, filed 11 Aug 2017.